reason report
bottom line rais pt report
revenu ebitda ep beat strong perform
us uk uk segment rebound nice ss
revenu growth yoy improv patient day length stay
lo price though challeng nh shift referr
local govern like remain appear convert
bed nurs camh children adolesc mental
health servic meet nh capac demand off-set headwind
us also good quarter revenu price lo trend
improv hand facil impact volum trend
compani note expect remain swb
yoy activ address staf pressur
us/uk continu enter jv open de novo add
bed us drive growth still compani remain lever
may limit access capit de novo larg scale without
share rais increas ebitda mm
ebitda mm
beat revenu ebitda ep revenu
compar consensu expect adj ebitda
expect ep
expect ebitda margin declin yoy
expect due swb pressur exhibit
uk rebound nice ss revenu growth yoy
improv patient day lo price
proactiv convert bed meet servic demand nh need
capac new camh bed abl convert nurs
home bed provid nh bed still manag state
challeng nh shift referr local govern
like continu remaind even possibl
us also report good quarter revenu price
lo trend improv volum trend deceler qoq yoy
state hand facil impact volum
expect ramp throughout year expect volum
remain price growth appear sustain commerci
payor medicar rate increas payor mix also appear
stabl compani see increas medicaid
also shift acut mix exhibit
ev/ebitda
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth lt ep compound-annual-growth-rate
compani inform leerink partner llc research
revenu million
pleas refer page import disclosur price chart analyst certif
swb yoy activ address staf pressur
us/uk uk nh negoti rate increas
nurs union remain optimist also
creat temporari bank employe fill staf need
renegoti agenc contract rfp us
pressur isol market overal feel good
proactiv measur take address staf need
ac jv remain opportun expect add two jv
chattanooga tn ohio pipelin jv remain
rich variou jv approv process expect
current jv de novo posit ebitda impact
reiter ebitda guidanc mm
midpoint line consensu ep guidanc increas due
rais revenu ebitda ep estim
increas ebitda mm ebitda
capit deploy opportun drive growth remain
lever may share rais larg larg
acquisit nonetheless expect add bed
pipelin remain rich manag state look acut
comprehens treatment opportun
centuri cure impend legisl opioid
bill expect year could provid opioid fund ahcc
current outpati clinic treat patient day everi
day year treatment expect fund help
residenti bed treat opioid great degre alcohol
rais pt pt contempl
rais pt report revenu ebitda ep beat
strong perform us uk
uk segment rebound nice ss revenu growth yoy improv
patient day length stay lo price though challeng nh shift referr
local govern like remain appear convert bed nurs
camh children adolesc mental health servic meet nh capac demand
off-set headwind us also good quarter revenu price lo trend
improv hand facil impact volum trend compani note
expect remain swb yoy activ address staf
pressur us/uk continu enter jv open de novo add bed
us drive growth still compani remain lever may limit access capit
de novo larg scale without share rais increas ebitda
mm ebitda mm
beat revenu ebitda ep revenu compar consensu
expect adj ebitda expect
ep expect ebitda margin declin yoy
expect due swb pressur
uk rebound nice ss revenu growth yoy improv patient
day lo price proactiv convert bed meet servic demand
nh need capac new camh bed abl convert nurs home
bed provid nh bed still manag state challeng nh
shift referr local govern like continu remaind
even possibl
net rev/pati day qoq yoy despit uk challeng
us also report good quarter revenu price lo trend improv
volum trend deceler qoq yoy state hand facil
impact volum expect ramp throughout year expect volum
remain price growth appear sustain commerci payor medicar
rate increas payor mix also appear stabl compani see
increas medicaid also shift acut mix
swb yoy activ address staf pressur us/uk
uk nh negoti rate increas nurs union remain
optimist also creat temporari bank employe fill staf need
renegoti agenc contract rfp us pressur isol
market overal feel good proactiv measur take address staf
ac jv remain opportun expect add two jv chattanooga
tn ohio pipelin jv remain rich variou jv approv
process expect current jv de novo posit ebitda impact
reiter ebitda guidanc mm midpoint line
consensu ep guidanc increas due tax benefit
rais revenu ebitda ep estim increas
ebitda mm ebitda mm
compani guidanc compani guidanc oper net us inpati uk inpati acadia healthcar compani inc
capit deploy opportun drive growth remain lever
may share rais larg larg acquisit nonetheless expect add
bed pipelin remain rich manag state look acut
comprehens treatment opportun
centuri cure impend legisl opioid bill expect year could
provid opioid fund ahcc current outpati clinic treat patient
day everi day year treatment expect fund help residenti
bed treat opioid great degre alcohol abus
driver leerink ss growth uk ss growth driven volum price includ gradual ramp imd exclus bed addsramp de de novo facil uk censu staf issu continu moder leerink acadia healthcar compani inc
rais pt pt contempl ev/ebitda
pt contempl ev/ebitda ebitda
primari valuat methodolog base ev/ebitda rel rel
ev/ebitda also track function compani histori hospit group
averag assess potenti ev/ebitda expans next month base
forward forecast contempl underli fundament implic healthcar
reform dcf valuat leverag forward forecast wacc termin
growth rate point potenti multipl expans along sector company-
specif catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
market perform price target base ev/ebitda
adjust ebitda
downsid risk valuat includ
risk higher acquisit multipl slow acquisit driven growth
financi posit result oper
uk reli publicli fund entiti unit kingdom
revenu loss reduct fund chang procur method
primari valuat methodolog base rel ev/ebitda rel
ev/ebitda track function compani histori hospit group averag
assess potenti ev/ebitda expans next month base forward
forecast contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
point potenti multipl expans along sector compani specif
catalyst expect greater potenti multipl expans dcf valuat point
significantli upsid peer current trade level base rate
outperform price target base ev/ebitda
downsid risk valuat includ
possibl delay medicaid expans current non-expans state
acut care segment highli concentr la vega texa
cut govern commerci payer reimburs
declin receiv collect rate
pay mix pressur behavior segment
incom provis doubt net expensessalari oper ebitda depreci oper non-oper ebit net interest incom tax incom yoy net incom averag share million dilut dilut yoy non-recur item metricsrevenu growth expense/net opex/net debt/gross inc
hospit usinpati chang chang chang hospit ukinpati chang chang revenu chang acadia healthcar compani inc
